Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 18Cisplatin 18Cetuximab 13Carboplatin 10Magnetic Resonance Spectroscopy 9Specimen Handling 8Docetaxel 8Paclitaxel 7Radiotherapy, Intensity-Modulated 6Platinum 6Nivolumab 61,2-diaminocyclohexaneplatinum II citrate 6dostarlimab 4Radiotherapy 4Immunoglobulin G 4Fluorouracil 4Disulfides 4Biopsy 4(225)Ac-DOTA-c(RGDyK) 4atezolizumab 3Radiation 3Bevacizumab 3cemiplimab 2amivantamab 2abemaciclib 2Taxes 2Fulvestrant 2130-nm albumin-bound paclitaxel 2zimberelimab 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Receptors, Vascular Endothelial Growth Factor × 30 days × Clear all
NCT04777994 2026-06-04

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Calico Life Sciences LLC

Phase 1 Recruiting
248 enrolled
GenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡